Literature DB >> 8358722

Interaction of a polyamine analogue, 1,19-bis-(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines.

H S Basu1, M Pellarin, B G Feuerstein, A Shirahata, K Samejima, D F Deen, L J Marton.   

Abstract

Computer graphics modeling and physicochemical studies of spermine-DNA interactions, as well as experiments in cell culture, indicate that a polyamine analogue with strong affinity for nucleic acids but poor ability to condense and aggregate DNA in vitro should act as an antiproliferative agent if it can enter cells. On the basis of our studies of polyamine-DNA interactions, we designed a pentamine, 1,19-bis(ethylamino)-5,10,15- triazanonadecane (BE-4-4-4-4), that had these characteristics. Measurement of melting temperature and ultraviolet light scattering studies show that the affinity of this analogue for calf-thymus DNA is about 4 times higher than that of spermine, whereas its ability to aggregate DNA is slightly poorer than that of spermine. Studies in U-87 MG, U-251 MG, SF-126, SF-188, SF-763, SF-767, and DAOY human brain tumor cells in tissue culture showed that treatment for more than 96 h with concentrations of 5 microM BE-4-4-4-4 or greater inhibited growth; decreased levels of putrescine, spermidine, and spermine; and decreased colony-forming ability in all cell lines. The cytotoxicity of the analogue varied among cell lines; DAOY and SF-767 were the most sensitive and the most resistant lines, respectively. In SF-763 cells, growth inhibition by BE-4-4-4-4 could be partially reversed by the addition of putrescine, spermidine, or spermine 1 day after BE-4-4-4-4 addition, but in U-251 MG cells, growth inhibition was reversed only by spermine and not by other polyamines. When any of the naturally occurring polyamines was added simultaneously with BE-4-4-4-4, growth inhibition was completely blocked. The data suggest that a threshold intracellular concentration of BE-4-4-4-4 is needed to manifest the growth-inhibitory and cytotoxic effects. In most cell lines, once that threshold level is reached, the growth-inhibitory and cytotoxic properties of the analogue are manifest irrespective of cellular polyamine levels. Further increases in the BE-4-4-4-4 concentration or incubation time reduce the intracellular polyamine levels but do not significantly increase growth inhibition. In U-87 MG and DAOY cells, however, prolonged incubation with higher concentrations of BE-4-4-4-4 causes additional growth inhibition along with depletion of intracellular polyamines.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358722

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Novel synthetic polyamines are effective in the treatment of experimental microsporidiosis, an opportunistic AIDS-associated infection.

Authors:  Cyrus J Bacchi; Louis M Weiss; Schenella Lane; Benjamin Frydman; Aldonia Valasinas; Venodhar Reddy; Jerry S Sun; Laurence J Marton; Imitiaz A Khan; Magali Moretto; Nigel Yarlett; Murray Wittner
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Depletion of intracellular polyamines relieves inward rectification of potassium channels.

Authors:  S L Shyng; Q Sha; T Ferrigni; A N Lopatin; C G Nichols
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Effects of the S-adenosylmethionine decarboxylase inhibitor, 5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine, on cell growth and polyamine metabolism and transport in Chinese hamster ovary cell cultures.

Authors:  T L Byers; R S Wechter; R H Hu; A E Pegg
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

4.  Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells.

Authors:  Qingsong Zhu; Yi Huang; Laurence J Marton; Patrick M Woster; Nancy E Davidson; Robert A Casero
Journal:  Amino Acids       Date:  2011-07-30       Impact factor: 3.520

5.  Antizyme induction by polyamine analogues as a factor of cell growth inhibition.

Authors:  John L A Mitchell; Aviva Leyser; Michelle S Holtorff; Jill S Bates; Benjamin Frydman; Aldonia L Valasinas; Venodhar K Reddy; Laurence J Marton
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

6.  A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.

Authors:  Hirak S Basu; Todd A Thompson; Dawn R Church; Cynthia C Clower; Farideh Mehraein-Ghomi; Corey A Amlong; Christopher T Martin; Patrick M Woster; Mary J Lindstrom; George Wilding
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

7.  Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes.

Authors:  Yi Huang; Tracy Murray Stewart; Yu Wu; Stephen B Baylin; Laurence J Marton; Brandy Perkins; Richard J Jones; Patrick M Woster; Robert A Casero
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

8.  Two polyamine analogs (BE-4-4-4 and BE-4-4-4-4) directly affect growth, survival, and cell cycle progression in two human brain tumor cell lines.

Authors:  C J Bergeron; H S Basu; L J Marton; D F Deen; M Pellarin; B G Feuerstein
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

9.  The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.

Authors:  Allison Pledgie-Tracy; Madhavi Billam; Amy Hacker; Michele D Sobolewski; Patrick M Woster; Zhe Zhang; Robert A Casero; Nancy E Davidson
Journal:  Cancer Chemother Pharmacol       Date:  2009-08-30       Impact factor: 3.333

10.  A new model for disruption of the ornithine decarboxylase gene, SPE1, in Saccharomyces cerevisiae exhibits growth arrest and genetic instability at the MAT locus.

Authors:  B Schwartz; A Hittelman; L Daneshvar; H S Basu; L J Marton; B G Feuerstein
Journal:  Biochem J       Date:  1995-11-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.